Anti-vascular endothelial growth factor therapy and renal thrombotic microangiopathy

Archives of Ophthalmology

Volumn 129, Issue 8, 2011, Pages 1082-

  Sorenson, Christine M ^a   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; EVIDENCE BASED PRACTICE; GENE TARGETING; GLOMERULOPATHY; GLOMERULUS FILTRATION; KIDNEY CELL; KIDNEY INJURY; MOUSE; NEOPLASM; NONHUMAN; NOTE; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 80051572246     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.199     Document Type: Note

References (9)

1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358(24):2606-2617.
2. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration. Surv Ophthalmol. 2003;48(3):257-293.
3. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28(1):1-18.
4. Ellis LM, Hicklin DJ. VEGF-targeted therapy. Nat Rev Cancer. 2008;8(8):579-591.
5. Rosenfeld PJ, Brown DM, Heier JS, et al MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431. (Pubitemid 44511557)
6. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration. Ophthalmology. 2009;116(1):57-65, e5.
7. Subramanian ML, Abedi G, Ness S, et al. Bevacizumab vs ranibizumab for age-related macular degeneration. Eye (Lond). 2010;24(11):1708-1715.
8. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129-1136. (Pubitemid 351398487)
9. Sison K, Eremina V, Baelde H, et al. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol. 2010;21(10):1691-1701.